Back
Innoviva 10K Form
Buy
56
INVA
Innoviva
Last Price:
19.62
Seasonality Move:
1.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INVA News And Ratings
See the #1 stock for the next 7 days that we like better than INVA
INVA Financial Statistics
Sales & Book Value
| Annual Sales: | $310.46M |
|---|---|
| Cash Flow: | $43.72M |
| Price / Cash Flow: | 9.91 |
| Annual Sales: | $10.64 |
| Price / Book: | 1.85 |
Profitability
| EPS (TTM): | 1.65000 |
|---|---|
| Net Income (TTM): | $145.42M |
| Gross Margin: | $267.82M |
| Return on Equity: | 22.53% |
| Return on Assets: | 12.03% |
Innoviva Earnings Forecast
Key Innoviva Financial Ratios
- The Gross Profit Margin over the past 16 years for INVA is 86.27%.
- The Selling, General & Administrative Expenses for INVA have been equal to 31.64% of Gross Profit Margin.
- The Research & Development expenses have been 10.93% of Revenue.
- The Interest Expense is 10.66% of Operating Income.
- The Net Earning history of INVA is 57.89% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 16 years.
Innoviva Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INVA |
| CUSIP: | 45781M |
| Website: | inva.com |
Debt
| Debt-to-Equity Ratio: | 0.67 |
|---|---|
| Current Ratio: | 12.7 |
| Quick Ratio: | 11.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.94 |
|---|---|
| Forward P/E Ratio: | 17.25 |